Cercacor is a company focused on creating user-friendly, non-invasive monitoring technologies with the aim of empowering individuals to better understand their bodies, improve fitness levels, and reach their full potential. The company's flagship product, Ember, is designed to provide valuable insights into individuals' internal parameters. However, it's important to note that Ember has not yet received FDA clearance as a medical device and is not suitable for monitoring hemoglobin for medical conditions. Founded in 1998, Cercacor is a leader in the Health Care, Information Technology, Medical Devices, and Sports industries. The company's non-invasive technologies, developed under the name Masimo rainbow SET (Signal Extraction Technology), are widely used in top-tier hospitals globally. Cercacor has recently received a $4.89M Venture Round investment on 29 November 2017. With its dedicated team and passion for problem-solving, the company continues to explore and develop innovative solutions to help individuals achieve extraordinary results.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $4.89M | - | 29 Nov 2017 | |
Venture Round | $3.00M | - | 05 Dec 2016 |
No recent news or press coverage available for Cercacor.